Navigation Links
Two Pharmaceutical Executives Join TheraQuest Management Team
Date:6/24/2010

BLUE BELL, Pa., June 24 /PRNewswire/ -- TheraQuest Biosciences, Inc., a clinical stage pain management company today announced the appointment of Dr. Danny Kao, PhD, JD, as Senior Vice President, Pharmaceutical Development and General Counsel and Douglas R. Baum, MS as Senior Vice President, Business Development. On June 22, 2010, TheraQuest unveiled its analgesic product pipeline and provided a status update on its lead programs in chronic pain and neuropathic pain.

Dr. Najib Babul, CEO, said, "We have added two seasoned executives with more than 30 years of combined analgesic drug development experience to our senior management team.  The addition of outstanding, multi-talented pharma executives like Danny and Doug is a key step in TheraQuest's evolution as a company. Combined with our new product line-up, this move positions TheraQuest for significant progress in near future."

Biographical Summary of Management Team Additions

Danny Kao, PhD, JD joins TheraQuest as Senior Vice President, Pharmaceutical Development and General Counsel. Previously, Dr. Kao was Director, Strategic Development and Director, Formulation Development at Endo Pharmaceuticals.  Dr. Kao has developed several extended release dosage forms, including first to file generic formulations bioequivalent to OxyContin® and MS Contin®.  Dr. Kao received his master's degree in industrial pharmacy from the St. John's University, New York, his PhD in pharmaceutical sciences from the University of Kentucky and his JD from Touro College Law Center. Dr. Kao is a registered patent attorney at the USPTO and is admitted to practice law in New York and New Jersey.

Douglas R. Baum, MS joins TheraQuest as Senior Vice President, Business Development. Mr. Baum has been involved in analgesic drug development for over 20 years with SCIREX Corporation and with its new corporate entity, Premier Research Group.  He has extensive business development experience, working across a number of classes and formulations of analgesics. Mr. Baum served as VP, Strategic Development in the Analgesia & Rheumatology at SCIREX and later as Senior VP, Early Development Unit and VP, Global Business Development at Premier Research. He has significant operational experience with P&L responsibility, having served as Project Director and Program Director in analgesia. Mr. Baum has authored over 20 scientific publications in the field of pain. He received his bachelor's and master's degree from the University of Texas at Austin.


'/>"/>
SOURCE TheraQuest Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
2. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
3. K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors
4. Pharmaceutical Market Research: A Strategic Business Partner in 2011
5. Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
6. Effective Social Media Marketing Strategies for Pharmaceutical Market (2010 - 2015): MarketsandMarkets
7. CSafe Signs Master Lease With Cathay Pacific Airways to Further Enhance Healthcare and Pharmaceutical Transport
8. Isis Pharmaceuticals to Present at The Wells Fargo 2010 Healthcare Conference
9. Obamas Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets (Pharmaceuticals, Medical Devices and Health Insurance)
10. Pharmaceutical and Biotech Executives Must Manage and Optimize Key Opinion Leaders or Fall Behind in the Marketplace
11. Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... LAS VEGAS , June 26, 2016 ... movement to value-based care operating models within the health ... that enable greater financial efficiency , Deloitte offers ... address the key business issues impacting efficient cost optimization: ... alignment , These services facilitate better outcomes and ...
(Date:6/24/2016)... 2016  Collagen Matrix, Inc., ("Collagen Matrix") the ... of collagen and mineral based medical devices for ... Bill Messer has joined the company as ... the growing portfolio of oral surgery, neurosurgery, orthopaedic ... joins the Collagen Matrix executive team as an ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... ... 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... service members that have been wounded in battle and their families. Venture Construction Group ...
(Date:6/24/2016)... ... 2016 , ... Advanced Plastic Surgery Institute ( http://www.advancedplasticsurgeryinstitute.com ), ... official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, owns the practice, ... says the decision to support the pageant in an official capacity is a ...
Breaking Medicine News(10 mins):